SEC Form 4 · accession 0001140361-17-012886
REPLIGEN CORP · RGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jon Snodgres
Officer — Chief Financial Officer
Period of report
Mar 17, 2017
Accepted (ET)
Mar 21, 2017 · 9:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000730272
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 17, 2017 | S | 1,909 | $34.9115 | D | 23,789 | D | |
| Common Stock | Mar 17, 2017 | M | 4,000 | $24.50 | A | 27,789 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $24.50 | Mar 17, 2017 | M | 4,000 | D | — | Jul 14, 2024 | Common Stock | 4,000 | 6,000 | D |
Explanation of responses
- F12,000 shares vest and become exercisable on each of the following dates: 7/14/2015, 7/14/2016, 7/14/2017, 7/14/2018 and 7/14/2019.